ABCB1 and ovarian carcinoma: In contrast, there are studies showing that ABCB1 c.3435C>T TT variant does not justify the significant interindividual variability in paclitaxel pharmacokinetics46 and did not associate with the occurrence of neurotoxicity in their patients with breast or ovarian cancer.47